Medical Devices Startups

1 investor

Unable to determine company business from page content. The page appears to be an investor relations contact page in Chinese for a company with headquarters in Shenzhen.

1 investor

BioKier develops oral products for managing lipids and glucose in type 2 diabetes and cardiometabolic disorders, designed to replicate the metabolic benefits of bariatric surgery through colon-targeted nutrient delivery. The company is a clinical-stage biotech pursuing regulatory approval via the 505(b)2 NDA pathway.

1 investor

BioKine develops immunotherapy drug candidates targeting cancer metastasis and treatment resistance, with its lead product BL-8040 in multiple clinical trials including stem cell mobilization, acute myeloid leukemia, and pancreatic carcinoma.

1 investor

BioLamina develops full-length human recombinant laminin proteins and related cell culture substrates for research and clinical applications. The company's products support the growth and differentiation of pluripotent stem cells, tissue-specific cells, and organoid development in both 2D and 3D culture environments.

1 investor

BioLife Solutions develops biopreservation media, cryopreservation tools, storage systems, and closed-system cell processing solutions for cell and gene therapy manufacturing. It serves bioprocess engineers, therapy developers, and contract development and manufacturing organizations (CDMOs), with regulatory support for GMP, FDA, and EMA compliance.

1 investor

BioLink is a biotechnology company that develops and manufactures process equipment and consumables for life science applications, including recombinant protein drugs, vaccines, antibody drugs, cell therapy, and gene therapy production. The company supplies upstream cell culture, disposable storage and downstream chromatography, filtration, and hydration products along with process development services.

1 investor

Biologic Input Output Systems develops neural interface technology to restore natural movement and sensation for individuals with limb loss, enabling intuitive control of prosthetic limbs through direct brain-machine connections.

1 investor

Biologos is a GMP-certified manufacturer of custom cell culture media, buffers, and reagents for biopharmaceutical and research customers. The company specializes in rapid formulation and aseptic manufacturing of biologics-related products to support disease treatment and prevention efforts.

1 investor

Biolyst supplies tools, products, and consulting services to clinicians and research scientists advancing discovery in the life sciences. The company specializes in supporting laboratory and clinical workflows through comprehensive product portfolios and strategic partnerships with healthcare and research institutions.

1 investor

Biolytx Pharmaceuticals is developing a novel antibiotic peptide, currently in pre-clinical trials, to treat serious hospital-acquired infections including those resistant to existing antibiotics. It operates in the biotechnology and pharmaceutical drug development sector.

1 investor

Biomarq Health develops a wearable, injectable multi-analyte biosensor platform that continuously monitors biochemical markers such as glucose, lactate, ketones, cortisol, and kidney-related analytes from a single sensor. Its first product targets affordable continuous glucose monitoring for people with type 1, type 2, and pre-diabetes, with planned applications in chronic kidney disease, pregnancy monitoring, and healthspan research.

1 investor

Biomarx develops automated liquid biopsy diagnostics using biosensing technologies for early cancer and disease detection, delivering test results in under two hours at low cost. Its products target clinicians and healthcare providers seeking rapid, affordable precision diagnostics for personalised medicine.

1 investor

Biomerics is a vertically integrated contract manufacturer for interventional medical devices, offering engineering, materials, and process expertise through 12 facilities. The company serves original equipment manufacturers in the medical device market with comprehensive design-to-manufacturing capabilities.

1 investor

Bioness Medical develops neuromodulation systems, robotic systems, and software-based therapy programs for patients with central nervous system disorders and orthopedic injuries. The company's offerings aim to improve patient outcomes and enhance efficiency for healthcare providers.

1 investor

Bioness Medical develops neuromodulation, robotic, and software-based medical technologies for patients with central nervous system disorders and orthopedic injuries. The company's products serve healthcare providers seeking to improve patient outcomes and operational efficiency.

1 investor

Bionic Sight develops gene therapy treatments for inherited blindness conditions, leveraging expertise in optogenetics and viral vector delivery to restore vision in patients with retinitis pigmentosa and geographic atrophy.

1 investor

Bionova Medical develops Foundation DRS Solo, a biodegradable, collagen-free chitosan-glycosaminoglycan dermal regeneration scaffold for advanced wound care. The device is intended to promote healing of full and partial thickness wounds, ulcers, burns, surgical wounds, and other skin injuries.

1 investor

Bionure Investment is a company based in Barcelona focused on developing solutions for neurodegenerative diseases affecting patients worldwide. The organization operates in the biotech and digital health sectors.

1 investor

BioPhenoMA develops a protein detection technology platform based on its proprietary TN-cyclon (improved enzyme cycling method) to quantify ultra-trace amounts of proteins in real biological samples while preserving their structure and localization. It targets biomedical and life-science researchers analyzing the mechanisms of biological phenomena.

1 investor

Biopremier supplies molecular diagnostic products and laboratory equipment, including real-time PCR and ELISA test kits for detecting pathogens, mycotoxins, and food adulteration in food, animal feed, and environmental and veterinary samples. It also provides laboratory instruments and services such as biosafety cabinets, plate readers, and molecular biology lab setup and training for food safety and veterinary diagnostics.

1 investor

Bioprex Medical develops antibacterial coatings for medical devices to prevent infections by inhibiting biofilm formation on device surfaces. The company serves healthcare providers and medical device manufacturers seeking to reduce device-associated infection risk.

1 investor

BiopSense develops an automated cartridge for extracting cell-free nucleic acids (DNA, RNA, cells, proteins) from large blood volumes without centrifugation, aimed at simplifying liquid biopsy sample preparation and transport for cancer diagnostics and monitoring. It serves oncology clinical laboratories and healthcare providers to enable non-invasive cancer treatment monitoring and personalization.

1 investor

Bioretec develops fully biodegradable orthopedic implants for fracture healing and orthopedic surgery, including the RemeOs product line based on magnesium alloy and the Activa line of bioabsorbable implants. The company serves orthopedic surgeons and patients globally across approximately 40 countries.

1 investor